umarjan11/Medical-qna huggingface dataset:
Question: How many people are affected by recurrent hydatidiform mole ?

Answer: Hydatidiform moles occur in 1 in 600 to 1,000 pregnancies in western countries and are more common in developing countries. One to six percent of previously affected women will have a recurrent hydatidiform mole.
Question: How many people are affected by ZAP70-related severe combined immunodeficiency ?

Answer: ZAP70-related SCID is a rare disorder. Only about 20 affected individuals have been identified. The prevalence of SCID from all genetic causes combined is approximately 1 in 50,000.
Question: Who is at risk for Primary Sclerosing Cholangitis? ?

Answer: Most people with PSC are adults but the disease also occurs in children. The average age at diagnosis is 40. PSC is more common in men than women. Having family members with PSC may increase a person's risk for developing PSC.
Question: How to prevent Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis ?

Answer: Researchers do not know how to prevent microscopic colitis. However, researchers do believe that people who follow the recommendations of their health care provider may be able to prevent relapses of microscopic colitis.
Question: Who is at risk for Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis? ?

Answer: No. Unlike the other inflammatory bowel diseases, such as Crohns disease and ulcerative colitis, microscopic colitis does not increase a persons risk of getting colon cancer.
Question: How to diagnose Alzheimer's Disease ?

Answer: The time from diagnosis of Alzheimers disease to death varies. It can be as little as 3 or 4 years if the person is over 80 years old when diagnosed or as long as 10 years or more if the person is younger.
Question: What is (are) Age-related Macular Degeneration ?

Answer: Wet AMD occurs when abnormal blood vessels behind the retina start to grow under the macula. With wet AMD, loss of central vision can occur quickly. Wet AMD is considered to be advanced AMD and is more severe than the dry form.
Question: What is (are) Psoriasis ?

Answer: Oral or injected medications for psoriasis include methotrexate, cycloclosporine, oral retinoids, and biologics. These therapies, prescribed by your doctor, work in different ways to help control the underlying disease process.
Question: What are the treatments for Prescription and Illicit Drug Abuse ?

Answer: People can receive treatment as outpatients (they live at home and visit the doctor or other provider) or through inpatient services (they live temporarily at a special facility where they get treatment). The support of family and friends is important during the treatment process.
Question: Is Schizencephaly inherited ?

Answer: Is schizencephaly inherited? Schizencephaly is not thought to be inherited in most cases and it rarely affects more than one person in a family. A few cases of familial schizencephaly have been linked to changes (mutations) in the EMX2 gene.
Question: Is Hypokalemic periodic paralysis inherited ?

Answer: How is hypokalemic periodic paralysis inherited? This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition.
Question: Is Kienbock's disease inherited ?

Answer: Is Kienbock's disease inherited? There is currently no evidence that Kienbock's disease is inherited. However, the cause of Kienbock's disease is not known. It is possible that unidentified genetic factors contribute to the development of the condition.
Question: What causes Reticulohistiocytoma ?

Answer: What causes reticulohistiocytoma? While it is known that reticulohistiocytoma (RH) develop due to a rapid production of immune cells (histiocytes) in the skin or soft tissues, the cause of this process is not currently known.
Question: What causes Warthin tumor ?

Answer: What causes Warthin tumor? The exact underlying cause of Warthin tumor is currently unknown. However, smoking is thought to increase the risk of developing the tumor. Some studies suggest that radiation exposure and autoimmune disorders may also be associated with Warthin tumor.
Question: What are the treatments for Fumarase deficiency ?

Answer: How might fumarase deficiency be treated? There is currently no effective treatment for fumarase deficiency. Nutritional intervention may be appropriate for children with feeding difficulties. Physical therapy and wheelchairs can also be useful for some individuals.
Question: What are the treatments for Pontocerebellar hypoplasia type 1 ?

Answer: How might pontocerebellar hypoplasia type 1 be treated? There is no standard therapy for pontocerebellar hypoplasia type 1. Treatment is symptomatic and supportive.
Question: What is the outlook for Glossopharyngeal Neuralgia ?

Answer: Some individuals recover from an initial attack and never have another. Others will experience clusters of attacks followed by periods of short or long remission. Individuals may lose weight if they fear that chewing, drinking, or eating will cause an attack.
Question: What is the outlook for Hypersomnia ?

Answer: The prognosis for persons with hypersomnia depends on the cause of the disorder. While the disorder itself is not life threatening, it can have serious consequences, such as automobile accidents caused by falling asleep while driving. The attacks usually continue indefinitely.
Question: what research (or clinical trials) is being done for Hypersomnia ?

Answer: The NINDS supports and conducts research on sleep disorders such as hypersomnia. The goal of this research is to increase scientific understanding of the condition, find improved methods of diagnosing and treating it, and discover ways to prevent it.
Question: what research (or clinical trials) is being done for Klver-Bucy Syndrome ?

Answer: NINDS supports and conducts research on neurobehavioral disorders such as Klver-Bucy syndrome. Much of the research focuses on learning more about these disorders and finding ways to prevent and treat them.
Question: what research (or clinical trials) is being done for Transient Ischemic Attack ?

Answer: NINDS is the leading supporter of research on stroke and TIA in the U.S. and sponsors studies ranging from clinical trials to investigations of basic biological mechanisms as well as studies with animals.
Question: What are the treatments for Cephalic Disorders ?

Answer: Treatments for cephalic disorders depend upon the particular type of disorder. For most cephalic disorders, treatment is only symptomatic and supportive. In some cases, anticonvulsant medications shunts, or physical therapy are appropriate.
Question: what research (or clinical trials) is being done for Monomelic Amyotrophy ?

Answer: The NINDS conducts and supports a broad range of research on motor neuron diseases. The goals of these studies are to increase understanding of these disorders and to find ways to treat, prevent, and ultimately cure them.
Question: What is the outlook for Melkersson-Rosenthal Syndrome ?

Answer: Melkersson-Rosenthal syndrome may recur intermittently after its first appearance. It can become a chronic disorder. Follow-up care should exclude the development of Crohn's disease or sarcoidosis.
Question: What is the outlook for Chiari Malformation ?

Answer: Many people with Type I CM are asymptomatic and do not know they have the condition. Many individuals with the more severe types of CM and have surgery see a reduction in their symptoms and/or prolonged periods of relative stability, although paralysis is generally permanent.
Question: How many people are affected by Hutchinson-Gilford progeria syndrome ?

Answer: This condition is very rare; it is reported to occur in 1 in 4 million newborns worldwide. More than 130 cases have been reported in the scientific literature since the condition was first described in 1886.
Question: Is boomerang dysplasia inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Almost all cases result from new mutations in the gene and occur in people with no history of the disorder in their family.
Question: How many people are affected by X-linked creatine deficiency ?

Answer: The prevalence of X-linked creatine deficiency is unknown. More than 150 affected individuals have been identified. The disorder has been estimated to account for between 1 and 2 percent of males with intellectual disability.
Question: Is Meesmann corneal dystrophy inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of an altered KRT12 or KRT3 gene in each cell is sufficient to cause the disorder. In most cases, an affected person inherits the condition from an affected parent.
Question: How many people are affected by X-linked adrenoleukodystrophy ?

Answer: The prevalence of X-linked adrenoleukodystrophy is 1 in 20,000 to 50,000 individuals worldwide. This condition occurs with a similar frequency in all populations.
Question: How many people are affected by Legg-Calv-Perthes disease ?

Answer: The incidence of Legg-Calv-Perthes disease varies by population. The condition is most common in white populations, in which it affects an estimated 1 to 3 in 20,000 children under age 15.
Question: How many people are affected by autoimmune Addison disease ?

Answer: Addison disease affects approximately 11 to 14 in 100,000 people of European descent. The autoimmune form of the disorder is the most common form in developed countries, accounting for up to 90 percent of cases.
Question: How many people are affected by diastrophic dysplasia ?

Answer: Although the exact incidence of this condition is unknown, researchers estimate that it affects about 1 in 100,000 newborns. Diastrophic dysplasia occurs in all populations but appears to be particularly common in Finland.
Question: How many people are affected by Costello syndrome ?

Answer: This condition is very rare; it probably affects 200 to 300 people worldwide. Reported estimates of Costello syndrome prevalence range from 1 in 300,000 to 1 in 1.25 million people.
Question: How many people are affected by dystonia 6 ?

Answer: The prevalence of dystonia 6 is unknown. Studies indicate that it likely accounts for between 1 and 3 percent of all cases of dystonia. For reasons that are unclear, the disorder appears to be slightly more prevalent in females than in males.
Question: How many people are affected by CHMP2B-related frontotemporal dementia ?

Answer: CHMP2B-related frontotemporal dementia has been reported in one large family in Denmark and a few unrelated individuals from other countries. This disease appears to be a rare form of frontotemporal dementia.
Question: Is familial paroxysmal kinesigenic dyskinesia inherited ?

Answer: This condition is inherited in an autosomal dominant pattern. Autosomal dominant inheritance means that one copy of an altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition.
Question: How many people are affected by Graves disease ?

Answer: Graves disease affects about 1 in 200 people. The disease occurs more often in women than in men, which may be related to hormonal factors. Graves disease is the most common cause of thyroid overactivity (hyperthyroidism) in the United States.
Question: How many people are affected by progressive familial heart block ?

Answer: The prevalence of progressive familial heart block is unknown. In the United States, about 1 in 5,000 individuals have complete heart block from any cause; worldwide, about 1 in 2,500 individuals have complete heart block.
Question: What is (are) What I need to know about Lactose Intolerance ?

Answer: Lactose
                
*
                
intestine
                
lactase
                
,
                
enzyme
                
*See the Pronunciation Guide for tips on how to say the words in bold type.
Question: What are the treatments for Dumping Syndrome ?

Answer: Treatment for dumping syndrome includes changes in eating, diet, and nutrition; medication; and, in some cases, surgery. Many people with dumping syndrome have mild symptoms that improve over time with simple dietary changes.
Question: What is (are) Lung Cancer ?

Answer: Lung cancer occurs when malignant tumors form in the tissue of the lung. The lungs are a pair of sponge-like organs. The right lung has three sections, called lobes, and is larger than the left lung, which has two lobes.
Question: What is (are) Creating a Family Health History ?

Answer: In a genetic test, a small sample of blood, saliva, or tissue is taken to examine a person's genes. Sometimes, genetic testing can detect diseases that may be preventable or treatable. This type of testing is available for thousands of conditions.
Question: Is Spondylothoracic dysostosis inherited ?

Answer: Is spondylothoracic dysostosis genetic? Yes. Spondylothoracic dysostosis is caused by mutations in the MESP2 gene. It is inherited in an autosomal recessive fashion.
Question: What causes Marden-Walker syndrome ?

Answer: What causes Marden-Walker syndrome? The underlying cause of Marden-Walker syndrome has not been clearly established. It appears to be a developmental disorder of the central nervous system and is likely to be the expression of various heterogeneous diseases.
Question: What is (are) Carbon baby syndrome ?

Answer: Carbon baby syndrome, also known as universal acquired melanosis, is a rare form of hyperpigmentation. The skin of affected infants progressively darkens over the first years of life in the absence of other symptoms. The cause of the condition is unknown.
Question: What are the treatments for Gerstmann-Straussler-Scheinker Disease ?

Answer: There is no cure for GSS, nor are there any known treatments to slow progression of the disease. Current therapies are aimed at alleviating symptoms and making the patient as comfortable as possible.
Question: What is the outlook for Craniosynostosis ?

Answer: The prognosis for craniosynostosis varies depending on whether single or multiple cranial sutures are involved or other abnormalities are present. The prognosis is better for those with single suture involvement and no associated abnormalities.
Question: What are the treatments for Occipital Neuralgia ?

Answer: Treatment is generally symptomatic and includes massage and rest. In some cases, antidepressants may be used when the pain is particularly severe. Other treatments may include local nerve blocks and injections of steroids directly into the affected area.
Question: What is the outlook for Zellweger Syndrome ?

Answer: The prognosis for infants with Zellweger syndrome is poor. Most infants do not survive past the first 6 months, and usually succumb to respiratory distress, gastrointestinal bleeding, or liver failure.
Question: What is the outlook for Hemicrania Continua ?

Answer: Individuals may obtain complete to near-complete relief of symptoms with proper medical attention and daily medication. Some people may not be able to tolerate long-term use of indomethacin and may have to rely on less effective NSAIDs.
Question: what research (or clinical trials) is being done for Brown-Sequard Syndrome ?

Answer: The NINDS supports and conducts a wide range of research on spinal cord disorders such as BSS. The goal of this research is to find ways to prevent, treat, and, ultimately, cure these disorders.
Question: What is the outlook for Syncope ?

Answer: Syncope is a dramatic event and can be life-threatening if not treated properly. Generally, however, people recover completely within minutes to hours. If syncope is symptomatic of an underlying condition, then the prognosis will reflect the course of the disorder.
Question: What is the outlook for Cerebral Arteriosclerosis ?

Answer: Cerebral arteriosclerosis can lead to life threatening health events such as ischemic or hemorrhagic strokes. People who survive stroke may have long-term neurological and motor impairments.
Question: How many people are affected by mucolipidosis III gamma ?

Answer: Mucolipidosis III gamma is a rare disorder, although its exact prevalence is unknown. It is estimated to occur in about 1 in 100,000 to 400,000 individuals worldwide.
Question: How many people are affected by trisomy 13 ?

Answer: Trisomy 13 occurs in about 1 in 16,000 newborns. Although women of any age can have a child with trisomy 13, the chance of having a child with this condition increases as a woman gets older.
Question: How many people are affected by bladder cancer ?

Answer: In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women. About 45,000 men and 17,000 women are diagnosed with bladder cancer each year.
Question: How many people are affected by Alzheimer disease ?

Answer: Alzheimer disease currently affects an estimated 2.4 million to 4.5 million Americans. Because the risk of developing Alzheimer disease increases with age and more people are living longer, the number of people with this disease is expected to increase significantly in coming decades.
Question: How many people are affected by congenital hypothyroidism ?

Answer: Congenital hypothyroidism affects an estimated 1 in 2,000 to 4,000 newborns. For reasons that remain unclear, congenital hypothyroidism affects more than twice as many females as males.
Question: How many people are affected by McKusick-Kaufman syndrome ?

Answer: This condition was first described in the Old Order Amish population, where it affects an estimated 1 in 10,000 people. The incidence of McKusick-Kaufman syndrome in non-Amish populations is unknown.
Question: How many people are affected by Pelizaeus-Merzbacher disease ?

Answer: The prevalence of Pelizaeus-Merzbacher disease is estimated to be 1 in 200,000 to 500,000 males in the United States. This condition rarely affects females.
Question: Is Czech dysplasia inherited ?

Answer: Czech dysplasia is inherited in an autosomal dominant pattern, which means one copy of the altered COL2A1 gene in each cell is sufficient to cause the disorder.  All known individuals with Czech dysplasia inherited the mutation from a parent with the condition.
Question: How many people are affected by primary carnitine deficiency ?

Answer: The incidence of primary carnitine deficiency in the general population is approximately 1 in 100,000 newborns. In Japan, this disorder affects 1 in every 40,000 newborns.
Question: Who is at risk for Glaucoma? ?

Answer: Encourage them to have a comprehensive dilated eye exam at least once every two years. Remember -- lowering eye pressure in glaucoma's early stages slows progression of the disease and helps save vision.  Get tips on finding an eye care professional.
Question: What causes Prostate Cancer ?

Answer: Scientists don't know exactly what causes prostate cancer. They cannot explain why one man gets prostate cancer and another does not. However, they have been able to identify some risk factors that are associated with the disease. A risk factor is anything that increases your chances of getting a disease.
Question: What are the symptoms of Diabetic Retinopathy ?

Answer: Diabetic retinopathy often has no early warning signs. Don't wait for symptoms. Be sure to have a comprehensive dilated eye exam at least once a year.  Learn more about a comprehensive dilated eye exam.
Question: What is (are) High Blood Cholesterol ?

Answer: An HDL (good) cholesterol level more than 60 mg/dL is desirable for most people. Here are the ranges for HDL cholesterol levels. Do you know how your HDL cholesterol level compares?
Question: Do you have information about Teens' Page

Answer: Summary : If you are a teenager, this page is for you!     It includes materials specifically for you - not for your parents - about health and safety for teens. There are quizzes, games and lots of cool web sites for you to explore. Have fun!
Question: How to diagnose Bronchiolitis obliterans organizing pneumonia ?

Answer: How is bronchiolitis obliterans organizing pneumonia (BOOP) diagnosed? BOOP is typically diagnosed by lung biopsy, although imaging tests and pulmonary function tests can also provide information for diagnosis.
Question: What causes Progressive transformation of germinal centers ?

Answer: What causes progressive transformation of germinal centers?  Is it genetic? The cause of progressive transformation of germinal centers (PTGC) is currently unknown.  Also, there is no evidence in the medical literature that PTGC is a genetic condition.
Question: How to diagnose Desmoplastic infantile ganglioglioma ?

Answer: How are desmoplastic infantile gangliomas diagnosed? In addition to detecting the signs and symptoms commonly seen in DIGs, head CT scans and MRIs may reveal the presence of this type of brain tumor.
Question: What causes Pineal cyst ?

Answer: What causes pineal cysts? The exact cause of pineal cysts is unknown. However, some studies suggest that bleeding in the pineal region or hormonal influences may play a role in the development and progression of pineal cysts.
Question: What is the outlook for Corticobasal Degeneration ?

Answer: Corticobasal degeneration usually progresses slowly over the course of 6 to 8 years. Death is generally caused by pneumonia or other complications of severe debility such as sepsis or pulmonary embolism.
Question: What is the outlook for Chorea ?

Answer: The prognosis for individuals with chorea varies depending on the type of chorea and the associated disease. Huntington's disease is a progressive, and ultimately, fatal disease. Syndenham's chorea is treatable and curable.
Question: What are the treatments for Dravet Syndrome ?

Answer: Seizures in Dravet syndrome are difficult to control, but can be reduced by anticonvulsant drugs. A ketogenic diet, high in fats and low in carbohydrates, also may be beneficial.
Question: what research (or clinical trials) is being done for Coffin Lowry Syndrome ?

Answer: The NINDS supports and conducts research on genetic disorders, such as Coffin-Lowry syndrome, in an effort to find ways to prevent, treat, and ultimately cure these disorders.
Question: What are the treatments for Behcet's Disease ?

Answer: Treatment for Behcet's disease is symptomatic and supportive. Medication may be prescribed to reduce inflammation and/or regulate the immune system. Immunosuppressive therapy may be considered.
Question: What is the outlook for Myopathy ?

Answer: The prognosis for individuals with a myopathy varies. Some individuals have a normal life span and little or no disability. For others, however, the disorder may be progressive, severely disabling, life-threatening, or fatal.
Question: What are the treatments for Cerebro-Oculo-Facio-Skeletal Syndrome (COFS) ?

Answer: Treatment is supportive and symptomatic. Individuals with the disorder often require tube feeding. Because COFS is genetic, genetic counseling is available.
Question: How many people are affected by North American Indian childhood cirrhosis ?

Answer: North American Indian childhood cirrhosis has been found only in children of Ojibway-Cree descent in the Abitibi region of northwestern Quebec, Canada. At least 30 affected individuals from this population have been reported.
Question: Is sialuria inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most reported cases have occurred in people with no known history of the disorder in their family and may result from new mutations in the gene.
Question: How many people are affected by 5-alpha reductase deficiency ?

Answer: 5-alpha reductase deficiency is a rare condition; the exact incidence is unknown. Large families with affected members have been found in several countries, including the Dominican Republic, Papua New Guinea, Turkey, and Egypt.
Question: How many people are affected by mucopolysaccharidosis type I ?

Answer: Severe MPS I occurs in approximately 1 in 100,000 newborns. Attenuated MPS I is less common and occurs in about 1 in 500,000 newborns.